Synthetic Drugs in East and Southeast Asia: Latest developments and challenges

By United Nations Office on Drugs and Crime (UNODC)

The versatility of synthetic drugs and flexibility of their manufacture is driving a constant evolution of the illicit synthetic drug market. The dynamic nature of the market continues to present a significant challenge globally, requiring a multifaceted, comprehensive approach to address the problem. In November 2021, UNODC launched the Synthetic Drug Strategy as a framework to support countries in developing evidence and science-based responses to address this ongoing challenge. The strategy includes four spheres of action, namely, multilateralism and international cooperation, early warning on emerging synthetic drug threats, promoting science-informed health responses, and strengthening counter-narcotic interventions. East and Southeast Asia, which is home to one of the largest methamphetamine markets in the world, is a key region for implementation of the strategy. Amidst the continued impact of the COVID-19 pandemic and other recent developments, organised crime groups in the region have shown their adaptability and ingenuity to capitalise on the situation and expand their operations.

Vienna: UNODC, Global SMART Programme , 2022. 36p.